Machine Learning Model Identifies Patients With Stage IV EGFR+ NSCLC Likely to Benefit from ...

Retrieved on: 2021-02-02 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

Machine Learning Model Identifies Patients With Stage IV EGFR+ NSCLC Likely to Benefit from .... View article details on hiswai:

Excerpt

According to the study authors, an end-to-end deep learning approach to generate CT-based biomarkers may help produce more rapid clinical ...

Article found on: www.cancernetwork.com